[ad_1]
The European Commission is approving a deal that will allow it to purchase up to 300 million doses of the coronavirus vaccine from Pfizer in the United States and BioNTech in Germany, European Commission spokesman Erik Mamer said in Brussels on Wednesday, MTI reported.
Mamer told a press conference that this is the fourth contract that the EU commission is concluding with pharmaceutical companies to procure a coronavirus vaccine.
The agreement will initially allow all EU member states to purchase 200 million doses of vaccine, as well as the possibility to request an additional 100 million doses.
The vaccine, developed by the two companies, is the most promising coronavirus vaccine ever produced, so the European Commission is working to distribute it in Europe as soon as it becomes available, he added.
Featured Image: AFP
[ad_2]
